Product Name | MF | CAS | Details |
---|
Wnt pathway activator 2 | C17H15NO4 | 1360540-82-4 | Details |
VU6005806 | C17H16F3N7O2S | 2180914-37-6 | Details |
USP7-IN-6 | C41H43N7O4S | 2166586-47-4 | Details |
TXNIP-IN-1 | C12H12N2O4 | 1268955-50-5 | Details |
UbcH5c-IN-1 | C22H21BrO3 | 2123480-72-6 | Details |
TSHR antagonist S37a | C25H20N2O3S2 | 2143452-20-2 | Details |
TRPA1 Antagonist 1 | C24H23F6N5NaO7PS | 1984825-08-2 | Details |
TL02-59 dihydrochloride | C32H35ClF3N5O4 | 2415263-06-6 | Details |
SMYD2-IN-1 | C25H25Cl2F2N7O2 | 2023788-96-5 | Details |
TP-008 | C20H15ClFN5O2 | 1976038-41-1 | Details |
Top1 inhibitor 1 | C24H22N6O2 | 2302772-05-8 | Details |
TGFBR1-IN-1 | C23H17N5O2S | 2170830-26-7 | Details |
TD-0212 TFA | C30H35F4N3O6S | 1073549-11-7 | Details |
Telomerase-IN-3 | C19H16ClN5O3 | 150096-77-8 | Details |
TDP1 Inhibitor-1 | C26H26N2O5 | 2248702-80-7 | Details |
TAB29 | C28H22O3 | 2361144-71-8 | Details |
TAK-828F | C28H32FN3O5 | 1854901-94-2 | Details |
Synucleozid hydrochloride | C22H21ClN6 | 2741856-68-6 | Details |
SSTR5 antagonist 1 | C28H34FN3O5 | 1628741-91-2 | Details |
Syncytial Virus Inhibitor-1 | C23H26N4O3S | 1422496-79-4 | Details |
SRT3657 | C40H54N8O6S | 1383551-17-4 | Details |
Sitravatinib malate | C37H35F2N5O9S | 2244864-88-6 | Details |
SHMT-IN-1 | C18H16Cl2N4O | 1508286-18-7 | Details |
S-8510 phosphate | C12H13N4O6P | 151466-23-8 | Details |
S1PR1 modulator 1 | C23H24N2O3S | 2328109-05-1 | Details |
RP-001 hydrochloride | C24H25ClN4O4 | 1781880-34-9 | Details |
RIPK1-IN-3 | C22H19F3N6O3 | 2242677-36-5 | Details |
RAS GTPase inhibitor 1 | C27H28ClF4N5O2 | 2252242-32-1 | Details |
RIP2 Kinase Inhibitor 3 | C19H24N4O3S | 1398053-50-3 | Details |
Ribocil-C Racemate | C21H21N7OS | 2309762-18-1 | Details |
RORγt Inverse agonist 3 | C29H31Cl2N5O4S | 2364429-77-4 | Details |
ROR agonist-1 | C21H20F6N2O5S | 2361528-74-5 | Details |
Seltorexant hydrochloride | C21H23ClFN7O | 1293284-49-7 | Details |
RAF mutant-IN-1 | C23H17Cl2FN6O2S | 2340020-82-6 | Details |
(Rac)-BL-918 | C23H15F8N3OS | 2435589-07-2 | Details |
(Rac)-AMG8379 | C25H16ClF2N3O5S | 1641574-26-6 | Details |
(R)-MIK665 | C47H44ClFN6O6S | 1799831-02-9 | Details |
PD-1-IN-22 | C25H25N5O4 | 2349372-98-9 | Details |
PF-06726304 acetate | C24H25Cl2N3O5 | 2080306-28-9 | Details |
OTS186935 trihydrochloride | C25H27Cl2N5O2 | 2093401-85-3 | Details |
PERK-IN-3 | C22H16F2N4O2 | 1337532-08-7 | Details |
P-gp modulator 1 | C41H72N2O6 | 2249749-39-9 | Details |
Prolyl Hydroxylase inhibitor 1 | C19H18ClN5O4 | 2205125-60-4 | Details |
PI3K-IN-9 | C19H23N7O | 2360875-63-2 | Details |
PHT-7.3 | C24H23N3O3S | 1614225-93-2 | Details |
Pparδ agonist 1 | C26H27NO5 | 1902161-12-9 | Details |
QPX7728 methoxy acetoxy methy ester | C14H14BFO7 | 2170834-57-6 | Details |
QPX7728-OH disodium | C10H6BFNaO5- | 2170848-99-2 | Details |
MK-7145 | C26H30N2O6 | 1255204-84-2 | Details |
ML218 hydrochloride | C19H27Cl3N2O | 2319922-08-0 | Details |
NPD-1335 | C28H29N3O3 | 2376326-31-5 | Details |
NSC 601980 | C15H12N4 | 2070018-27-6 | Details |
Ebopiprant | C30H34FN3O5S2 | 2005486-31-5 | Details |
MARK-IN-2 | C18H18ClF2N5OS | 1314893-26-9 | Details |
Norverapamil-d7 | C26H29D7N2O4 | 263175-44-6 | Details |
6751-0002 | C17H12ClNO3 | 51505-10-3 | Details |
OT antagonist 3 | C21H20N6O2 | 925703-75-9 | Details |
NUCC-390 | C23H33N5O | 1060524-97-1 | Details |
OMDM-6 | C28H42N2O3 | 616884-67-4 | Details |
OT antagonist 1 | C22H22N4O3 | 479080-38-1 | Details |
MBM-17S | C32H34N6O6 | 2083621-91-2 | Details |
Menin-MLL inhibitor 4 | C32H38FN7O3 | 2169916-13-4 | Details |
Mcl1-IN-4 | C28H26N2O5S | 1580484-04-3 | Details |
MCB-3681 | C31H32F2N4O8 | 790704-42-6 | Details |
MTH1-IN-2 | C24H27N3O5S | 901044-91-5 | Details |
MARK-IN-1 | C22H23F2N7OS | 1109283-93-3 | Details |
MAGL-IN-1 | C22H24FNO3 | 2324160-91-8 | Details |
LpxH-IN-AZ1 | C21H22F3N3O3S | 901260-40-0 | Details |
Lp-PLA2-IN-2 | C19H23FN2O4S | 2071636-15-0 | Details |
Kv3 modulator 2 | C21H21N3O4 | 2101321-76-8 | Details |
Lp-PLA2-IN-3 | C20H13ClF3N3O3S | 2196245-16-4 | Details |
Kv3 modulator 3 | C19H18N4O3 | 1498186-01-8 | Details |
Blonanserin HCl | C23H31ClFN3 | 132812-45-4 | Details |
LY88074 Trimethyl ether | C24H20O4S | 63675-87-6 | Details |
KRAS inhibitor-4 | C30H39ClN8O | 2374152-69-7 | Details |
Kv3 modulator 1 | C20H20N4O4 | 1380696-64-9 | Details |
Kgp-IN-1 | C19H24F4N4O3 | 2097865-36-4 | Details |
IV-23 | C18H18BrNO4 | 2326007-49-0 | Details |
KDM4-IN-2 | C25H26N6O | 2369607-62-3 | Details |
hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
IDO/TDO-IN-1 | C25H24FN5 | 2033173-01-0 | Details |
hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
HS79 | C19H22N4S | 2138838-56-7 | Details |
IDO1 and HDAC1 Inhibitor | C25H22BrFN8O4 | 2227044-16-6 | Details |
IRAK4-IN-6 | C25H32N10O2 | 2454244-02-9 | Details |
HS80 | C19H22N4S | 2138838-57-8 | Details |
IQB-782 | C4H9N3O2S | 40454-21-5 | Details |
HL271 | C13H17ClF3N5O | 1422365-52-3 | Details |
GSK 690 Hydrochloride | C24H23N3O.ClH | 2436760-79-9 | Details |
HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
Epelsiban | C30H38N4O4 | 872599-83-2 | Details |
GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
FXIa-IN-1 | C20H19F3N4O5 | 1803271-50-2 | Details |
GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
GNE684 | C23 H24 N6 O3 | 2438637-64-8 | Details |
GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
FM26 | C22H15ClF3N3O3 | 2407981-35-3 | Details |
Product Total: Product Page: | ||||
90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 |